BioDelivery Sciences International Employee Directory
Pharmaceutical ManufacturingNorth Carolina, United States51-200 Employees
BioDelivery Sciences International is a mid-sized commercial-stage specialty pharmaceutical company based in Raleigh, North Carolina, focused on delivering therapies for chronic conditions. It pursues new applications of proven medicines through its own development programs or collaborations, using its proprietary drug-delivery technology to improve administration and patient experience. The company operates within pharmaceutical manufacturing, aiming to address unmet medical needs by bringing optimized therapies to market. Its customer focus centers on patients living with chronic diseases and the healthcare providers who treat them. A notable recent development is the U.S. commercial launch of ELYXYB, a ready-to-use oral solution of celecoxib for the acute treatment of migraine in adults, announced in February 2022, and described as the first and only FDA-approved ready-to-use oral solution for this indication.